Medicine and Dentistry
Radiation Therapy
100%
Metastatic Carcinoma
91%
Overall Survival
80%
Recurrent Disease
69%
Radiation Oncology
61%
Non Small Cell Lung Cancer
60%
Prostate Cancer
60%
Diseases
56%
Cancer
49%
Brain Metastasis
44%
Stereotactic Body Radiation Therapy
38%
Stereotactic Radiosurgery
36%
Low Drug Dose
35%
Malignant Neoplasm
35%
Neuroinflammation
35%
C57BL/6
35%
Cancer Therapy
35%
Neck
32%
Drug Megadose
30%
Clivus
30%
Volumetric Modulated Arc Therapy
30%
Myeloid Cell
30%
Brain Radiation
30%
Image-Guided Radiation Therapy
30%
Radiation Injury
30%
Oral Cancer
30%
Chemokine Receptor
30%
Transplantation
30%
Hemangioma
30%
Laryngoscopy
30%
Hepatocellular Carcinoma
30%
Remote Sensing
30%
Cellular Infiltration
30%
Small Cell Lung Cancer
30%
Palliative Radiation Therapy
30%
Lung Cancer Survival
30%
Cancer Diagnosis
30%
T Cell
30%
Isocenter
30%
Cancer Registry
30%
Gamma Chemokine
30%
Radiosurgery
30%
Multiple Myeloma
30%
Hypofractionated Radiotherapy
30%
Skull Irradiation
30%
Polyethylene Terephthalate
30%
Systemic Therapy
27%
Sequela
23%
Hazard Ratio
23%
Multivariate Analysis
20%
Keyphrases
Stereotactic Radiosurgery
97%
Brain Metastases
95%
Non-small Cell Lung Cancer (NSCLC)
73%
Overall Survival
66%
Intracranial Progression
60%
Multi-institutional Analysis
60%
Head-and-neck
47%
High Dose
45%
Stereotactic Body Radiotherapy
38%
Low-volume Metastasis
38%
C57BL
36%
Neuroinflammation
36%
Cancer Treatment
36%
Cancer Diagnosis
35%
Recurrence Pattern
34%
Synchronous Presentation
33%
Extracranial
33%
Cancer Registry
30%
Rectosigmoid Cancer
30%
Validation Studies
30%
Slit Ventricle
30%
Hypofractionated Radiation Therapy
30%
Stage Migration
30%
T Cell Infiltration
30%
Fiberoptic Laryngoscopy
30%
Small Cell Lung Cancer
30%
Simulation Workshop
30%
Survival Stage
30%
Infliximab
30%
Large Prostate
30%
Survival Improvement
30%
Prostate Volume
30%
Patients with Prostate Cancer
30%
Multidisciplinary Management
30%
CD11c
30%
Intraosseous Hemangioma
30%
Lung Cancer Survival
30%
Sarcoidosis
30%
Prognostic Model
30%
Mycophenolate Mofetil
30%
Voluntary Running
30%
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
30%
Cranial Irradiation
30%
Mouse Brain
30%
Myeloid Cells
30%
Simultaneous Integrated Boost
30%
Clivus
30%
Ultra-low Dose
30%
Hippocampal Neurogenesis
30%
Oral Cavity Cancer
30%
